Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) rose 0.3% on Friday . The company traded as high as $3.5480 and last traded at $3.5480. Approximately 336 shares traded hands during trading, a decline of 89% from the average daily volume of 3,174 shares. The stock had previously closed at $3.5370.
Relief Therapeutics Stock Up 0.3%
The stock has a fifty day moving average price of $3.71 and a 200-day moving average price of $3.29.
About Relief Therapeutics
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Further Reading
- Five stocks we like better than Relief Therapeutics
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Worried About Inflation? These 3 ETFs Offer Real Protection
- 3 Small Caps With Big Return Potential
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
